Clinical phenotypes of adults with monogenic and syndromic genetic obesity
Obesity · 2024
DOI: 10.1002/oby.24047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Mila S Welling und 9 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Phenotype, Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Elisabeth Foundation.
Abstract (Originalsprache)
Objective
Considering limited evidence on diagnostics of genetic obesity in adults, we evaluated phenotypes of adults with genetic obesity. Additionally, we assessed the applicability of Endocrine Society (ES) recommendations for genetic testing in pediatric obesity.
Methods
We compared clinical features, including age of onset of obesity and appetite, between adults with non‐syndromic monogenic obesity (MO), adults with syndromic obesity (SO), and adults with common obesity (CO) as control patients.
Results
A total of 79 adults with genetic obesity (32 with MO, 47 with SO) were compared with 186 control patients with CO. Median BMI was similar among the groups: 41.2, 39.5, and 38.7 kg/m 2 for patients with MO, SO, and CO, respectively. Median age of onset of obesity was 3 (IQR: 1–6) years in patients with MO, 9 (IQR: 4–13) years in patients with SO, and 21 (IQR: 13–33) years in patients with CO ( p < 0.001). Patients with genetic obesity more often reported increased appetite: 65.6%, 68.1%, and 33.9% in patients with MO, SO, and CO, respectively ( p < 0.001). Intellectual deficit and autism spectrum disorder were more prevalent in patients with SO (53.2% and 21.3%) compared with those with MO (3.1% and 6.3%) and CO (both 0.0%). The ES recommendations were fulfilled in 56.3%, 29.8%, and 2.7% of patients with MO, SO, and CO, respectively ( p < 0.001).
Conclusions
We found distinct phenotypes in adult genetic obesity. Additionally, we demonstrated low sensitivity for detecting genetic obesity in adults using pediatric ES recommendations, necessitating specific genetic testing recommendations in adult obesity care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Pediatrics, Division of Endocrinology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Human Genetics, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Emma Center for Personalized Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Mila S Welling, Cornelis J de Groot, Mariëtte R Boon, Lotte Kleinendorst, Jenny A Visser, Mieke M van Haelst, Erica L T van den Akker, Elisabeth F C van Rossum
Förderung
- Elisabeth Foundation
Zitieren
APA
Welling, M. S., Mohseni, M., Meeusen, R. E. H., de Groot, C. J., Boon, M. R., Kleinendorst, L., Visser, J. A., van Haelst, M. M., van den Akker, E. L. T., & van Rossum, E. F. C. (2024). Clinical phenotypes of adults with monogenic and syndromic genetic obesity. Obesity. https://doi.org/10.1002/oby.24047
Vancouver
Welling MS, Mohseni M, Meeusen REH, de Groot CJ, Boon MR, Kleinendorst L, et al. Clinical phenotypes of adults with monogenic and syndromic genetic obesity. Obesity. 2024. doi:10.1002/oby.24047
BibTeX
@article{Welling2024,
author = {Welling, Mila S and Mohseni, Mostafa and Meeusen, Renate E H and de Groot, Cornelis J and Boon, Mariëtte R and Kleinendorst, Lotte and Visser, Jenny A and van Haelst, Mieke M and van den Akker, Erica L T and van Rossum, Elisabeth F C},
title = {Clinical phenotypes of adults with monogenic and syndromic genetic obesity},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24047}
}
EUVIMED